This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Motor neuron disease (with DMD)
MND
muscular disease: Acquired, familial, and congenital disorders of skeletal muscle and smooth muscle.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
31 |
4. Check minimum number of eventsNone |
31 |
5. Include endpoints |
705 |
6. Filter based on genotype QC (FinnGen only) |
705 |
Extra metadata
- First used in FinnGen datafreeze
- DF3
- Parent code in ICD-10
- G710
- Name in latin
- Dystrophia musculorum gravis (Duchenne)
Similar endpoints
↥List of similar endpoints to
Motor neuron disease (with DMD)
based on the number of shared cases.
Similar with more cases:
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 705 | 277 | 428 |
| Unadjusted period prevalence (%) | 0.15 | 0.09 | 0.19 |
| Median age at first event (years) | 66.98 | 67.13 | 66.89 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 632
- Matched controls
- 6320
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G12.2
ICD-10 Finland
Motor neuron disease
+∞
323.0
579
*
N07XX02
ATC
riluzole; oral
+∞
166.1
152
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
102.1
138.5
149
19
N99
ICPC
Neurological disease other
419.6
136.3
132
*
R47.1
ICD-10 Finland
Dysarthria and anarthria
1551.8
133.3
125
*
J96.1
ICD-10 Finland
Chronic respiratory failure
37.6
120.6
155
54
JDB10
NOMESCO Finland
Percutaneous gastrostomy
101.8
120.6
130
16
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
26.8
107.1
151
73
R13
ICD-10 Finland
Dysphagia
17.2
94.4
156
118
Z51.5
ICD-10 Finland
Palliative care
11.8
84.9
168
188
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
24.9
81.7
117
57
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
22.2
76.7
114
62
N28
ICPC
Limited function/disability (N)
104.4
76.0
82
9
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
11.5
72.6
144
158
TAB00
NOMESCO Finland
Lumbar puncture
61.7
69.9
81
15
R4130
NOMESCO Finland
Speech therapy
54.4
68.4
81
17
G47.3
ICD-10 Finland
Sleep apnoea
24.6
66.4
95
45
A28
ICPC
Limited function/disability NOS
7.0
65.2
182
347
XG466
NOMESCO Finland
Sleep oxymetry
42.0
65.1
81
22
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
74.6
59.5
67
10
SPAT1229
SPAT
Assessment of need for aid
10.6
58.2
119
135
R5140
NOMESCO Finland
Monitoring the use of the aid
16.6
56.7
93
65
L28
ICPC
Limited function/disability (L)
6.0
54.8
172
373
WX725
NOMESCO Finland
Noninvasive ventilation
11.6
50.3
97
97
G12.9
ICD-10 Finland
Spinal muscular atrophy, unspecified
+∞
46.4
44
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
5.0
45.0
163
408
R1250
NOMESCO Finland
Evaluation of functional capability
47.1
42.9
52
12
TJD20
NOMESCO Finland
Change of gastrostomy tube
224.3
41.4
42
*
AA1AD
NOMESCO Finland
CT of head and brain
5.4
41.3
137
308
N03AE01
ATC
clonazepam; systemic
15.2
39.3
66
48
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
207.3
38.2
39
*
R4120
NOMESCO Finland
Occupational therapy
10.0
37.4
77
86
R1260
NOMESCO Finland
Evaluation of communicative skills
38.9
37.4
47
13
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
10.7
36.8
73
76
N29
ICPC
Neurological sympt/complt other
56.0
35.8
42
8
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
7.1
35.4
91
146
S06.0
ICD-10 Finland
Concussion
27.4
33.7
46
18
M03BX01
ATC
baclofen; systemic
67.2
33.4
38
6
R5599
NOMESCO Finland
Other rehabilitation service
17.1
32.6
52
33
SPAT1231
SPAT
Assessment of adjustments needed in living environment
25.4
32.3
45
19
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
13.2
32.1
57
47
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
41.4
31.5
39
10
XA800
NOMESCO Finland
Neuropsychological investigation
63.4
31.4
36
6
N18
ICPC
Paralysis/weakness
63.4
31.4
36
6
N19
ICPC
Speech disorder
37.6
30.9
39
11
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
48.9
30.9
37
8
G71.06
ICD-10 Finland
Muscular dystrophy severe [Duchenne]
+∞
30.4
29
*
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
9.7
29.9
62
70
R4190
NOMESCO Finland
Nutritional therapy
8.9
29.3
64
79
SPAT1216
SPAT
Assessment of functional ability
3.9
28.5
130
392
D21
ICPC
Swallowing problem
41.0
28.3
35
9
R47.8
ICD-10 Finland
Other and unspecified speech disturbances
104.8
27.9
30
*
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
18.6
27.4
42
24
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
7.3
27.4
68
103
G72.9
ICD-10 Finland
Myopathy, unspecified
+∞
27.3
26
*
SPAT1215
SPAT
Assessment of need for medical rehabilitation
12.5
27.2
49
42
G12.8
ICD-10 Finland
Other spinal muscular atrophies and related syndromes
+∞
26.2
25
*
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
5.4
25.3
80
166
SPAT1222
SPAT
Counselling/guidance promoting independent living
3.7
24.3
115
354
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
90.2
23.8
26
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.7
23.2
112
350
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
21.0
21.9
32
16
XG467
NOMESCO Finland
Nocturnal CO2 monitoring
+∞
20.9
20
*
N05BA04
ATC
oxazepam; oral
3.1
20.9
130
489
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
9.5
20.9
43
48
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
79.5
20.8
23
*
N06AB10
ATC
escitalopram; oral
4.0
20.7
88
246
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.7
20.6
168
749
G56.0
ICD-10 Finland
Carpal tunnel syndrome
11.5
20.4
38
35
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
7.0
20.4
51
78
XA402
NOMESCO Finland
ENMG
15.1
20.1
33
23
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.6
19.9
177
828
T05
ICPC
Feeding problem of adult
+∞
19.9
19
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
6.0
19.8
56
101
SPAT1234
SPAT
Support of social functional capacity
8.0
19.7
45
60
N03AX12
ATC
gabapentin; oral
3.7
18.9
88
265
N05AH04
ATC
quetiapine; oral
5.7
18.9
55
103
G31.0
ICD-10 Finland
Circumscribed brain atrophy
+∞
18.8
18
*
N06AX11
ATC
mirtazapine; oral
2.7
18.8
151
662
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
5.8
18.7
54
100
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.4
18.7
192
964
SPAT1245
SPAT
Provision of support and information to patient’s family members
6.5
17.9
47
77
XG416
NOMESCO Finland
Measurement of maximal airway pressure
+∞
17.8
17
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
+∞
17.8
17
*
G12.1
ICD-10 Finland
Other inherited spinal muscular atrophy
+∞
17.8
17
*
R25.3
ICD-10 Finland
Fasciculation
37.9
17.7
22
6
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
4.9
17.4
58
127
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
9.7
17.3
35
38
Z31.5
ICD-10 Finland
Genetic counselling
6.6
17.3
45
73
N06AB04
ATC
citalopram; systemic
3.2
17.1
96
333
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
8.8
16.9
36
43
XX9TE
NOMESCO Finland
Compementary ultrasound examination
65.1
16.8
19
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
11.2
16.6
31
29
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
14.8
16.4
27
19
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.7
16.3
75
223
Z50.5
ICD-10 Finland
Speech therapy
21.6
16.1
23
11
ACC51
NOMESCO Finland
Release of median nerve
61.6
15.8
18
*
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
+∞
15.7
15
*
3352A
ICD-9 Finland
Anterior horn cell disease, Motor neuron disease[SCLEROSIS LATERALIS AMYOTROPHICA]
+∞
15.7
15
*
SPAT1254
SPAT
Administration of medicine
2.9
14.9
97
372
NXL00
NOMESCO Finland
Biopsy of muscle
58.1
14.8
17
*
JDB01
NOMESCO Finland
Laparoscopic gastrostomy
+∞
14.6
14
*
G71.9
ICD-10 Finland
Primary disorder of muscle, unspecified
+∞
14.6
14
*
RS314
NOMESCO Finland
NA
+∞
14.6
14
*
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
82.0
14.6
16
*
GX2D5
NOMESCO Finland
Sleep oximetry
153.3
14.5
15
*
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
37.0
14.5
18
5
N02AA01
ATC
morphine; systemic, rectal
7.7
14.4
33
45
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
19.7
14.3
21
11
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
22.9
14.3
20
9
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
30.8
13.9
18
6
F80.1
ICD-10 Finland
Expressive language disorder
54.6
13.9
16
*
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
+∞
13.6
13
*
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
26.4
13.4
18
7
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.2
13.3
164
878
A06AD11
ATC
lactulose; oral
2.6
13.0
102
434
N05BA06
ATC
lorazepam; systemic, sublingual
5.7
13.0
37
68
G20
ICD-10 Finland
Parkinson disease
71.3
12.6
14
*
ABC60
NOMESCO Finland
Decompression of cervical spinal cord
71.3
12.6
14
*
XW5WT
NOMESCO Finland
Other blood specimen with radiologicl guidance
32.7
12.6
16
5
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
17.8
12.6
19
11
G71.08
ICD-10 Finland
Other muscular dystrophy
+∞
12.5
12
*
30041
ICD-8 Finland
Neuroses, Depressiva
+∞
12.5
12
*
RS340
NOMESCO Finland
NA
+∞
12.5
12
*
UDQ42
NOMESCO Finland
Endoscopic assessment of swallowing function
+∞
12.5
12
*
RK110
NOMESCO Finland
NA
20.5
12.5
18
9
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
132.4
12.5
13
*
UJC01
NOMESCO Finland
Scopy of lower throat
16.3
12.2
19
12
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
27.3
12.1
16
6
G62.8
ICD-10 Finland
Other specified polyneuropathies
66.2
11.6
13
*
M62.5
ICD-10 Finland
Muscle wasting and atrophy, not elsewhere classified
122.1
11.5
12
*
J96.0
ICD-10 Finland
Acute respiratory failure
10.8
11.3
21
20
G56.2
ICD-10 Finland
Lesion of ulnar nerve
20.5
11.2
16
8
R5110
SPAT
NA
7.6
11.0
25
34
N03AG01
ATC
valproic acid; systemic, rectal
15.8
10.9
17
11
N06DA02
ATC
donepezil; oral
28.6
10.8
14
5
N03AF01
ATC
carbamazepine; oral, rectal
7.2
10.6
25
36
N05AX08
ATC
risperidone; systemic
10.3
10.6
20
20
WX722
NOMESCO Finland
PEEP
6.4
10.5
27
44
RS211
NOMESCO Finland
NA
111.7
10.4
11
*
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
+∞
10.4
10
*
R47.0
ICD-10 Finland
Dysphasia and aphasia
+∞
10.4
10
*
N07AA02
ATC
pyridostigmine; systemic
+∞
10.4
10
*
Z93.1
ICD-10 Finland
Gastrostomy status
+∞
10.4
10
*
RS142
NOMESCO Finland
NA
+∞
10.4
10
*
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
9.0
10.3
21
24
XG410
NOMESCO Finland
Flow-volume spirometry
4.3
10.2
37
90
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
13.4
10.2
17
13
N05BA01
ATC
diazepam; systemic, rectal
2.8
10.1
67
259
R53
ICD-10 Finland
Malaise and fatigue
2.4
10.1
90
410
R06.0
ICD-10 Finland
Dyspnoea
2.0
10.1
139
771
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
14.9
10.0
16
11
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
12.4
9.9
17
14
R4110
NOMESCO Finland
Physiotherapy
1.9
9.7
153
889
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
13.6
9.7
16
12
J96.9
ICD-10 Finland
Respiratory failure, unspecified
55.8
9.7
11
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
55.8
9.7
11
*
N05AN01
ATC
lithium; oral
101.4
9.4
10
*
RS310
NOMESCO Finland
NA
101.4
9.4
10
*
XA421
NOMESCO Finland
Nocturnal polygraphy
101.4
9.4
10
*
G30.1
ICD-10 Finland
Alzheimer disease with late onset
17.8
9.4
14
8
A210_
NOMESCO Finland
NA
+∞
9.4
9
*
K11.72
ICD-10 Finland
Xerostomia
+∞
9.4
9
*
G71.00
ICD-10 Finland
Muscular dystrophy benign [Becker]
+∞
9.4
9
*
A120_
NOMESCO Finland
NA
+∞
9.4
9
*
G71.03
ICD-10 Finland
Muscular dystrophy autosomal recessive, childhood type, resembling Duchenne or Becker
+∞
9.4
9
*
G35
ICD-10 Finland
Multiple sclerosis
+∞
9.4
9
*
RS221
NOMESCO Finland
NA
10.9
9.3
17
16
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
9.3
111
579
A98
ICPC
Health maint/preventive medicine
0.5
9.2
446
5137
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
13.9
9.2
15
11
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
4.0
9.2
36
95
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
9.1
236
1619
SPAT1240
SPAT
Therapeutic discussion
3.8
9.1
37
101
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.1
9.1
48
161
M47.1
ICD-10 Finland
Other spondylosis with myelopathy
15.9
9.1
14
9
U04
ICPC
Incontinence urine
4.5
9.0
31
72
N06AA09
ATC
amitriptyline; systemic
3.2
8.9
47
157
RS230
NOMESCO Finland
NA
24.4
8.9
12
5
R49.08
ICD-10 Finland
Other specified dysphonia
7.3
8.8
20
28
S01.0
ICD-10 Finland
Open wound of scalp
3.1
8.7
47
160
N87
ICPC
Parkinsonism
50.7
8.7
10
*
RS122
NOMESCO Finland
NA
50.7
8.7
10
*
L99
ICPC
Musculoskeletal disease other
7.8
8.7
19
25
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.2
8.6
94
472
N05AH03
ATC
olanzapine; systemic
16.5
8.6
13
8
Z50.1
ICD-10 Finland
Other physical therapy
3.5
8.6
39
117
RS222
NOMESCO Finland
NA
10.2
8.6
16
16
K90
ICPC
Stroke/cerebrovascular accident
20.3
8.5
12
6
Z99.8
ICD-10 Finland
Dependence on other enabling machines and devices
91.2
8.4
9
*
WX1PA
NOMESCO Finland
Total body mineral density measurement with Dual energy X-ray absorptiometry (DXA)
91.2
8.4
9
*
WX723
NOMESCO Finland
CPAP therapy
91.2
8.4
9
*
3472A
ICD-9 Finland
Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]
+∞
8.3
8
*
Z43.1
ICD-10 Finland
Attention to gastrostomy
+∞
8.3
8
*
G81.9
ICD-10 Finland
Hemiplegia, unspecified
+∞
8.3
8
*
ACC53
NOMESCO Finland
Release of ulnar nerve
+∞
8.3
8
*
M41.4
ICD-10 Finland
Neuromuscular scoliosis
+∞
8.3
8
*
WX781
NOMESCO Finland
Remote monitoring, noninvasive ventilation
+∞
8.3
8
*
N81
ICPC
Injury nervous system other
+∞
8.3
8
*
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
8.7
8.3
17
20
SPAT1167
SPAT
Insertion of urinary catheter
4.5
8.3
28
64
WYA20
NOMESCO Finland
Home visit
14.7
8.2
13
9
SPAT1262
SPAT
Handing over of treatment supplies
2.0
8.2
107
577
SPAT1139
SPAT
Nutrition survey
5.2
8.1
24
48
RS311
NOMESCO Finland
NA
33.8
8.1
10
*
N02AA05
ATC
oxycodone; systemic
2.1
8.1
93
478
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
5.7
8.0
22
40
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
3.5
8.0
36
107
M48.0
ICD-10 Finland
Spinal stenosis
2.4
8.0
66
289
N06AX21
ATC
duloxetine; oral
3.4
7.9
36
109
N03AX16
ATC
pregabalin; oral
2.0
7.9
99
527
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
8.6
7.8
16
19
R42
ICD-10 Finland
Dizziness and giddiness
2.1
7.8
95
499
A04
ICPC
Weakness/tiredness general
2.6
7.8
57
235
Z73.6
ICD-10 Finland
Limitation of activities due to disability
15.2
7.7
12
8
RS313
NOMESCO Finland
NA
45.5
7.7
9
*
TNX05
NOMESCO Finland
Simple incision of soft tissue, unspecified region
80.9
7.4
8
*
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
80.9
7.4
8
*
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
13.5
7.4
12
9
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.6
7.4
31
88
H02AB13
ATC
deflazacort; oral
+∞
7.3
7
*
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
+∞
7.3
7
*
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
+∞
7.3
7
*
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
+∞
7.3
7
*
A220_
NOMESCO Finland
NA
+∞
7.3
7
*
G72.8
ICD-10 Finland
Other specified myopathies
+∞
7.3
7
*
G61.8
ICD-10 Finland
Other inflammatory polyneuropathies
+∞
7.3
7
*
G12.0
ICD-10 Finland
Infantile spinal muscular atrophy, type I [Werdnig-Hoffman]
+∞
7.3
7
*
85000
ICD-8 Finland
Concussion, Current or unspecified
+∞
7.3
7
*
G71.0
ICD-10 Finland
Muscular dystrophy
+∞
7.3
7
*
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
+∞
7.3
7
*
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
+∞
7.3
7
*
34800
ICD-8 Finland
Motor neurone disease, Amyotrophic lateral sclerosis
+∞
7.3
7
*
Z99.1
ICD-10 Finland
Dependence on respirator
+∞
7.3
7
*
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
15.9
7.2
11
7
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.1
7.2
38
129
N04BC05
ATC
pramipexole; oral
3.4
7.2
33
101
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
30.4
7.2
9
*
S28
ICPC
Limited function/disability (S)
30.4
7.2
9
*
Z75.5
ICD-10 Finland
Holiday relief care
30.4
7.2
9
*
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
10.2
7.1
13
13
L19
ICPC
Muscle symptom/complaint NOS
5.3
7.0
20
39
P29
ICPC
Psychological sympt/compl other
6.8
6.8
16
24
W19
ICD-10 Finland
Unspecified fall
2.6
6.8
48
194
JDB00
NOMESCO Finland
Gastrostomy
40.5
6.8
8
*
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
16.9
6.8
10
6
N05CF01
ATC
zopiclone; oral
1.7
6.7
156
1021
N06DX01
ATC
memantine; oral
22.8
6.7
9
*
RK320
NOMESCO Finland
NA
12.4
6.6
11
9
R41.0
ICD-10 Finland
Disorientation, unspecified
8.8
6.6
13
15
G44.2
ICD-10 Finland
Tension-type headache
3.2
6.5
32
104
K59.09
ICD-10 Finland
Constipation, unspecified
3.2
6.5
32
104
130
Kela drug reimbursment
Malignant tumour
0.3
6.4
11
387
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.8
6.4
41
155
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
70.5
6.4
7
*
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
70.5
6.4
7
*
N05AX12
ATC
aripiprazole; systemic
70.5
6.4
7
*
RS121
NOMESCO Finland
NA
70.5
6.4
7
*
TJD10
NOMESCO Finland
Insertion of other tube into stomach or duodenum
70.5
6.4
7
*
G99.2
ICD-10 Finland
Myelopathy in diseases classified elsewhere
+∞
6.3
6
*
G99.2*M47.1
ICD-10 Finland
Spondylogenic compression of spinal cord
+∞
6.3
6
*
G31.9
ICD-10 Finland
Degenerative disease of nervous system, unspecified
+∞
6.3
6
*
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
+∞
6.3
6
*
RK410
NOMESCO Finland
NA
+∞
6.3
6
*
N86
ICPC
Multiple sclerosis
+∞
6.3
6
*
4340A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral thrombosis
+∞
6.3
6
*
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
+∞
6.3
6
*
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
+∞
6.3
6
*
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
+∞
6.3
6
*
Z43.0
ICD-10 Finland
Attention to tracheostomy
+∞
6.3
6
*
G54.9
ICD-10 Finland
Nerve root and plexus disorder, unspecified
+∞
6.3
6
*
M54.1
ICD-10 Finland
Radiculopathy
4.2
6.2
22
54
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
26.9
6.2
8
*
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
4.0
6.2
23
59
R06.5
ICD-10 Finland
Mouth breathing
3.1
6.2
32
108
SPAT1252
SPAT
Overall medication plan or its review
2.8
6.1
37
139
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
68
12
62.61
121.85
1.0
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
65
11
64.99
117.26
1.0
1.0
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
76
31
27.36
109.16
1.1
1.5
e6/l
9.1
195.2
0.47
62
21
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
75
31
26.95
107.18
1.2
1.5
e6/l
718.5
821.9
0.04
62
22
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
351
1109
5.31
106.58
2.5
1.8
u/l
480.6
194.3
1.59
335
1020
(3044290) Cell count panel - Cerebral spinal fluid
75
33
25.31
104.66
1.1
1.6
—
—
—
0
0
(3009343) pH of Capillary blood
154
266
7.13
89.36
5.2
4.2
ph
7.4
7.4
1.66
21
29
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
150
253
7.26
89.01
5.0
4.2
mmol/l
3.2
1.7
4.01
137
186
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
155
271
7.05
88.88
5.3
4.2
kpa
5.7
5.0
10.72
149
247
(3019060) Gas panel - Arterial blood
142
281
6.08
71.11
3.2
4.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
69
8
95.51
63.19
1.0
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
66
9
80.54
59.21
1.1
1.0
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
79
106
8.27
56.66
5.5
4.0
mmol/l
28.1
24.4
5.76
69
90
(3022313) Gas panel - Capillary blood
107
200
6.13
56.34
5.8
4.3
—
—
—
0
0
(4027681)
50
6
89.64
45.49
1.3
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
62
84
8.00
43.91
5.7
4.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
115
286
4.61
43.33
1.3
2.7
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
130
371
4.07
40.75
1.6
2.7
g/l
67.8
66.2
1.90
119
343
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
157
536
3.48
37.61
5.5
7.0
kpa
5.8
5.1
7.26
152
507
(3027801) Oxygen [Partial pressure] in Arterial blood
156
536
3.45
36.95
5.5
7.0
kpa
10.6
12.5
8.22
150
507
(3021901) Oxygen saturation in Capillary blood
55
82
7.19
35.72
4.2
3.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
29
18
16.76
34.21
1.3
1.8
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
151
534
3.33
33.94
5.5
7.1
mmol/l
4.0
0.8
17.69
131
417
(3016018) Differential panel - Cerebral spinal fluid
27
19
14.74
29.78
1.2
1.7
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
69
155
4.83
29.14
1.3
1.9
g/l
2.7
3.2
4.14
46
129
(3020891) Body temperature
68
154
4.78
28.43
4.1
4.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
71
167
4.62
28.34
1.3
1.8
g/l
6.5
7.5
4.42
46
129
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
71
167
4.62
28.34
1.3
1.8
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
71
167
4.62
28.34
1.3
1.8
g/l
3.6
3.7
0.08
46
125
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
68
162
4.54
26.69
1.1
1.8
g/l
10.2
10.5
0.25
47
139
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
56
126
4.74
23.54
1.7
2.3
ug/l
318.4
321.2
0.01
50
117
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
411
5346
0.45
23.27
3.6
4.7
mmol/l
2.8
2.7
1.03
346
4855
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
400
5227
0.46
22.08
3.4
4.2
mmol/l
4.8
4.6
1.48
338
4783
(3005719) IgG [Mass/volume] in Serum or Plasma
88
288
3.35
21.97
1.7
3.4
g/l
10.4
10.8
0.42
75
273
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
396
5186
0.46
21.77
3.5
4.2
mmol/l
1.5
1.5
0.45
336
4712
(3017569) Oxygen content in Arterial blood
23
23
10.30
20.36
1.9
2.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
388
5002
0.50
17.51
3.2
3.8
mmol/l
1.3
1.2
0.06
329
4506
(3019309) Folate [Moles/volume] in Red Blood Cells
157
787
2.28
16.87
1.7
1.7
nmol/l
1165.8
1163.2
0.01
124
578
(40767503) Oxygen content in Capillary blood by calculation
39
86
4.74
16.77
2.6
2.5
%
18.5
15.8
4.17
29
47
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
48
128
3.95
16.18
1.3
1.7
g/l
0.0
0.0
0.50
43
116
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
49
136
3.80
15.62
1.1
1.6
g/l
40.0
37.2
2.49
43
119
(3024561) Albumin [Mass/volume] in Serum or Plasma
310
2054
1.91
15.32
3.5
5.0
g/l
35.6
35.0
1.06
292
1909
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
46
126
3.84
14.94
1.1
1.7
g/l
0.0
0.0
0.00
41
114
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
50
146
3.61
14.81
1.4
2.0
g/l
0.2
1.6
1.77
43
124
(3012095) Magnesium [Moles/volume] in Serum or Plasma
141
716
2.21
14.50
2.4
3.8
mmol/l
0.8
0.8
0.34
122
665
(3006653) Thiamine [Moles/volume] in Blood
19
7
27.83
14.33
1.0
1.1
nmol/l
132.7
147.1
—
19
7
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
45
125
3.78
14.33
1.1
1.7
g/l
0.0
0.0
0.00
40
114
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
147
763
2.17
14.30
1.8
1.8
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
387
4854
0.55
13.22
4.6
5.5
mmol/mol
38.2
39.8
3.18
344
4441
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
15
15
10.20
13.17
3.9
2.2
ug/l
71.3
66.5
0.08
15
15
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
338
2382
1.80
13.09
6.1
6.5
mmol/l
1.2
1.2
3.51
280
2034
(3037522) Nuclear Ab [Titer] in Serum
104
489
2.32
12.77
1.3
1.3
titre
676.7
403.4
0.58
24
105
(3019977) pH of Arterial blood
17
23
7.55
11.88
1.5
2.0
ph
7.4
7.4
—
12
9
(3006184) Hemoglobin [Mass/volume] in Capillary blood
35
93
3.91
11.87
2.4
2.2
g/l
142.3
128.8
2.65
30
65
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
306
2163
1.73
11.20
6.3
5.8
mmol/l
1.2
1.2
0.53
277
1949
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
426
5127
0.57
11.16
3.9
4.4
mmol/l
5.8
5.9
1.13
379
4599
(3044927) Protein electrophoresis panel - Urine
22
43
5.25
10.85
1.1
1.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
523
5925
0.55
10.43
22.7
18.4
e9/l
6.8
6.6
0.40
507
5687
(3013826) Glucose [Moles/volume] in Serum or Plasma
371
2808
1.68
10.23
5.0
4.2
mmol/l
6.4
6.8
3.51
356
2626
(3000963) Hemoglobin [Mass/volume] in Blood
524
5927
0.55
10.22
22.9
18.5
g/l
135.2
135.9
0.48
518
5806
(3026361) Erythrocytes [#/volume] in Blood
524
5925
0.55
10.15
22.7
18.4
e12/l
4.5
4.5
1.04
507
5688
(3024731) MCV [Entitic volume]
524
5924
0.55
10.12
22.6
18.4
fl
91.5
91.2
0.73
516
5798
(3035941) MCH [Entitic mass]
524
5924
0.55
10.12
22.6
18.3
pg
30.4
30.4
0.18
516
5798
(3007461) Platelets [#/volume] in Blood
524
5922
0.55
10.05
22.7
18.4
e9/l
246.0
241.8
0.89
510
5704
(3026008) Bacteria identified in Urine by Culture
206
1336
1.77
9.99
3.3
2.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
412
4956
0.59
9.98
13.8
12.5
ml/min/173m2
94.5
76.0
23.73
337
3976
(3032080) INR in Blood by Coagulation assay
286
2036
1.68
9.86
8.5
9.2
inr
1.2
1.3
1.36
68
524
(40768804) Tissue Pathology biopsy report
131
2121
0.53
9.73
2.1
2.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
91
481
2.02
8.23
4.1
4.0
mmol/l
4.2
1.7
5.88
75
358
(3009542) Hematocrit [Volume Fraction] of Blood
405
4811
0.63
8.13
18.3
14.1
%
39.1
39.4
0.20
247
3370
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
10
11
9.21
8.10
1.0
1.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
98
537
1.96
8.00
1.8
1.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
502
5668
0.60
7.98
9.6
9.4
u/l
37.8
25.6
4.22
484
5409
(3020682) Albumin/Creatinine [Ratio] in Urine
100
1667
0.53
7.83
3.0
3.8
mg/mmol
10.8
7.8
0.35
54
1065
(1761868) Lipid panel - Serum or Plasma
111
1794
0.55
7.82
2.5
2.9
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
313
2379
1.57
7.73
4.9
5.6
e9/l
0.0
0.0
1.97
270
1973
(3003458) Phosphate [Moles/volume] in Serum or Plasma
106
606
1.88
7.61
4.3
5.6
mmol/l
1.1
1.1
0.28
96
560
(3001604) Monocytes [#/volume] in Blood
311
2371
1.56
7.51
4.9
5.5
e9/l
0.6
0.6
2.36
269
1967
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
96
539
1.90
7.28
1.8
1.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
85
458
1.97
7.27
1.3
1.5
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
318
2467
1.53
6.93
5.1
5.7
e9/l
0.2
0.2
3.31
278
2091
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
148
963
1.68
6.80
1.4
1.7
pmol/l
451.6
26263042.5
1.04
123
792
(3003129) Base excess in Capillary blood by calculation
10
6
16.88
6.76
1.4
2.0
mmol/l
5.6
4.2
—
10
6
(3019198) Lymphocytes [#/volume] in Blood
313
2443
1.51
6.50
5.0
5.6
e9/l
2.1
1.9
0.23
275
2082
(3044889) 12 lead EKG panel
304
3742
0.67
6.26
3.1
3.6
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
6
0
+∞
6.26
1.2
0.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
19
52
3.73
6.23
2.6
2.9
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
93
1489
0.57
6.09
2.5
3.3
ug/l
0.8
0.9
0.20
67
1033
(42870588) Differential panel, method unspecified - Blood
223
1642
1.52
6.01
4.6
5.9
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
20
60
3.40
5.76
2.0
1.2
u/l
6.0
9.8
0.78
12
48
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
47
222
2.20
5.71
4.2
3.0
%
0.6
0.6
0.14
42
214
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
22
72
3.12
5.53
1.2
1.2
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
53
268
2.06
5.42
6.5
9.6
mmol/l
27.1
24.6
6.14
46
251
(3023368) Bacteria identified in Blood by Culture
184
1327
1.52
5.38
3.9
4.1
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
73
414
1.85
5.37
6.8
7.5
mmol/l
1.2
1.3
0.90
68
405
(3019069) Monocytes/100 leukocytes in Blood
289
2282
1.45
5.37
4.8
6.0
%
8.2
9.0
4.88
275
2112
(3003338) MCHC [Mass/volume]
385
4473
0.69
5.34
21.6
16.6
g/l
332.5
332.7
0.13
378
4425
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
41
189
2.24
5.29
1.7
2.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
191
1393
1.51
5.28
3.0
4.1
ph
7.4
7.4
0.13
31
234
(3006504) Eosinophils/100 leukocytes in Blood
287
2270
1.45
5.25
4.6
5.8
%
2.4
2.9
3.42
271
2094
(3022096) Basophils/100 leukocytes in Blood
281
2216
1.45
5.21
4.6
5.8
%
0.6
0.7
1.03
267
2046
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
255
1975
1.46
5.21
1.8
1.9
pmol/l
94.6
94.2
0.05
140
993
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
8
6
13.46
5.09
2.5
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
30
123
2.50
5.02
1.4
1.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
61
336
1.89
4.92
4.1
3.7
ng/l
63.8
91.3
2.18
54
300
(3012516) Albumin [Mass/volume] in Urine
106
1559
0.62
4.80
2.3
3.1
mg/l
11201.2
144.6
4.57
65
1004
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
36
164
2.26
4.80
1.6
1.9
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
495
5462
0.69
4.79
15.0
11.7
—
—
—
0
0
(3002256) Pathology report gross observation
37
733
0.48
4.75
1.2
1.4
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
291
2342
1.41
4.70
4.7
5.9
%
25.8
27.6
1.91
275
2164
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
51
269
1.97
4.67
4.5
4.5
mmol/l
26.2
23.7
4.51
45
246
(3015377) Calcium [Moles/volume] in Serum or Plasma
202
1542
1.43
4.32
2.9
3.9
mmol/l
2.4
2.4
1.14
178
1328
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
9
288
0.30
4.31
1.3
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
51
278
1.90
4.26
10.2
9.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
113
1596
0.65
4.18
2.9
3.0
mmol/l
7.2
7.4
0.28
84
1324
(3022145) Colonoscopy Study observation
25
544
0.44
4.15
1.2
1.4
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
283
2303
1.38
4.15
4.7
5.7
%
59.4
57.1
2.53
270
2139
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
188
1430
1.43
4.07
2.9
3.2
u/l
43.7
37.5
0.43
182
1358
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
8
10
8.08
4.07
4.5
4.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
7
10.08
4.01
1.3
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
7
7
10.08
4.01
1.1
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
7
7
10.08
4.01
1.1
1.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
79
500
1.65
3.99
4.5
2.7
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
27
118
2.34
3.99
1.6
1.7
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
10
24
4.21
3.90
1.0
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
7
8
8.82
3.78
1.1
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
8
8.82
3.78
1.1
1.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
14
367
0.37
3.63
1.1
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
53
309
1.77
3.61
1.5
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
5
198
0.25
3.57
1.0
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
157
2012
0.72
3.32
3.8
4.6
%
22.2
21.9
0.11
81
1092
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
51
302
1.74
3.31
1.7
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
197
2434
0.74
3.30
3.7
5.5
ug/l
6.5
3.8
0.41
168
2190
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
7
11
6.41
3.19
1.0
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
132
985
1.42
3.12
3.6
4.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
11
34
3.27
3.07
1.4
1.0
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
513
5515
0.74
2.98
18.7
14.9
mmol/l
3.9
4.0
6.95
500
5333
(3019550) Sodium [Moles/volume] in Serum or Plasma
512
5503
0.75
2.94
18.9
14.7
mmol/l
139.7
139.7
0.29
503
5330
(3036481) Cortisol [Moles/volume] in Serum or Plasma
51
314
1.67
2.91
1.6
2.4
nmol/l
414.6
386.8
0.50
44
288
(3000991) Gas panel - Venous blood
68
453
1.55
2.83
8.5
8.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
23
3.95
2.78
2.0
4.6
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
5
6
8.38
2.75
1.0
1.0
%
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
5
6
8.38
2.75
4.6
1.5
mmol/l
1.2
1.1
—
5
6
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
5
6
8.38
2.75
3.0
1.5
mmol/l
1.1
1.1
—
5
6
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
37
617
0.58
2.74
2.8
4.9
ug/l
15.8
45.1
0.80
30
518
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
212
1740
1.31
2.71
4.3
3.1
ng/l
65.3
68.4
0.05
190
1216
(3031040) Bacteria [#/volume] in Urine by Automated count
361
3176
1.28
2.70
5.3
3.9
e6/l
52.0
1896.4
—
7
42
(3026493) Urate [Moles/volume] in Serum or Plasma
99
1326
0.71
2.66
2.8
2.7
umol/l
11425.0
8749.7
0.16
83
1150
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
15
4.70
2.60
1.0
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
7
7.18
2.55
1.0
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
7
7.18
2.55
1.0
1.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
19
88
2.19
2.53
1.6
1.5
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
21
102
2.09
2.49
4.3
5.5
%
69.1
63.7
0.66
21
102
(3014007) Fractional oxyhemoglobin in Arterial blood
48
304
1.62
2.49
9.5
9.1
%
91.0
94.5
1.78
48
304
(3013650) Neutrophils [#/volume] in Blood by Automated count
325
2842
1.27
2.48
6.4
9.0
e9/l
4.1
4.1
0.00
281
2400
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
23
423
0.53
2.42
1.5
1.8
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
6
12
5.03
2.40
1.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
6
12
5.03
2.40
1.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
6
12
5.03
2.40
1.0
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
6
12
5.03
2.40
1.0
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
20
97
2.09
2.39
1.1
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
11
40
2.78
2.38
2.4
5.7
%
13.2
10.0
1.77
11
40
(3014271) Vancomycin [Susceptibility]
7
18
3.92
2.25
2.7
2.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
71
503
1.46
2.24
2.3
1.7
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
10
36
2.80
2.21
1.1
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
9
30
3.03
2.15
1.8
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
30
3.03
2.15
1.8
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
24
130
1.88
2.15
1.4
1.6
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
14
62
2.28
2.09
1.9
3.4
e9/l
3.9
3.9
0.01
14
62
(3028707) Methadone [Presence] in Urine by Screen method
5
10
5.03
2.07
1.0
1.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
20
103
1.97
2.07
1.5
1.8
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
66
469
1.45
2.07
3.3
2.8
ng/l
155.0
231.6
1.05
60
428
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
15
4.02
2.04
1.7
2.4
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
12
50
2.42
2.03
2.2
1.9
%
89.3
89.2
0.02
12
50
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
21
3.36
1.97
1.3
2.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
32
505
0.62
1.95
1.4
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
14
64
2.21
1.95
2.0
3.8
%
60.6
55.7
0.88
14
64
(3004451) EKG impression Narrative
6
16
3.77
1.94
1.2
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
7
170
0.41
1.93
1.0
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
12
52
2.33
1.88
1.1
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
12
52
2.33
1.88
1.1
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
12
52
2.33
1.88
1.1
1.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
28
2.88
1.86
1.3
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
17
3.55
1.84
1.2
1.1
—
—
—
0
0
(3019225) pH of Specimen
65
472
1.42
1.83
3.8
3.6
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
19
101
1.91
1.82
1.3
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
19
101
1.91
1.82
1.3
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
16
80
2.02
1.81
1.8
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
50
347
1.47
1.79
1.4
1.4
%
1.5
1.4
0.31
42
296
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
121
972
1.30
1.78
3.5
3.6
ng/l
797.7
576.2
0.12
105
823
(3013707) Erythrocyte sedimentation rate by Westergren method
398
3641
1.21
1.78
3.9
3.7
mm/h
10.6
13.4
4.38
372
3321
(3019832) Treponema pallidum Ab [Presence] in Serum
24
139
1.75
1.77
1.5
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
23
132
1.77
1.75
2.6
3.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
6
18
3.35
1.75
2.5
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
30
2.69
1.72
1.1
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
30
2.69
1.72
1.1
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
30
2.69
1.72
1.1
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
30
2.69
1.72
1.1
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
7
24
2.94
1.72
1.1
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
22
126
1.77
1.69
1.5
1.6
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
8
31
2.60
1.66
1.0
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
14
69
2.05
1.65
1.8
1.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
7
25
2.82
1.65
2.0
2.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
208
2382
0.82
1.62
5.5
4.4
estimate
0.0
0.0
0.00
41
401
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
211
1828
1.22
1.62
2.8
2.2
nmol/l
77.4
79.2
0.39
183
1607
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
284
2537
1.20
1.58
4.8
6.7
umol/l
12.6
13.2
0.29
272
2400
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
27
169
1.62
1.54
1.9
2.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
33
2.44
1.54
1.0
1.1
—
—
—
0
0
(4062490)
8
33
2.44
1.54
1.0
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
20
115
1.76
1.54
4.5
4.4
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
5
125
0.40
1.51
1.6
3.3
u/ml
14.4
357.5
—
5
117
(4010399)
47
338
1.42
1.44
1.3
1.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
22
2.74
1.43
1.2
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
22
2.74
1.43
1.2
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
22
2.74
1.43
1.2
1.7
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
9
39
2.32
1.43
2.8
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
240
2683
0.84
1.40
2.8
2.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
74
1.91
1.40
1.7
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
27
174
1.57
1.39
3.5
3.6
g/l
0.2
0.2
0.05
13
86
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
124
0.40
1.37
1.6
1.3
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
15
82
1.85
1.36
1.5
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
17
2.95
1.36
1.2
3.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
37
0.00
1.34
0.0
1.5
—
1.0
—
0
37
(3026470) Cobalt [Mass/volume] in Blood
0
37
0.00
1.34
0.0
1.8
—
3.0
—
0
31
(3000034) Microalbumin [Mass/volume] in Urine
0
39
0.00
1.34
0.0
3.3
—
13.9
—
0
32
(3003327) Ova and parasites identified in Stool by Light microscopy
6
131
0.45
1.29
1.0
1.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
49
650
0.74
1.28
1.1
1.2
u/ml
11.2
19.9
0.57
18
235
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
44
2.06
1.27
3.4
2.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
37
262
1.44
1.25
1.4
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
9
45
2.01
1.23
1.0
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
318
2915
1.17
1.23
3.2
2.7
u/l
38.9
51.4
3.41
298
2655
(3009261) Glucose [Presence] in Urine by Test strip
216
2414
0.85
1.23
3.9
3.1
estimate
0.0
0.0
0.00
41
392
(3039443) Prostate specific Ag panel - Serum or Plasma
7
145
0.48
1.21
1.4
1.8
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
26
2.32
1.19
2.5
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
26
2.32
1.19
2.5
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
10
50
2.01
1.17
1.2
1.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
12
210
0.56
1.16
2.3
1.7
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
5
20
2.51
1.15
1.0
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
33
458
0.71
1.15
1.8
2.7
ug/g
114.1
145.6
0.37
28
362
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
16
95
1.70
1.14
1.5
1.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
212
2360
0.85
1.13
4.0
3.1
estimate
0.0
0.0
0.00
40
390
(3025941) Bacteria identified in Stool by Culture
13
218
0.59
1.09
1.5
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
95
1131
0.82
1.08
4.0
2.9
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
126
1081
1.20
1.07
1.4
1.5
nmol/l
20.7
20.6
0.02
116
892
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
33
2.13
1.05
2.3
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
9
46
1.97
1.04
1.0
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
60
1.85
1.03
1.0
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
48
1.89
1.00
1.2
1.8
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
172
1526
1.17
0.99
3.7
3.4
e6/l
51.6
79.9
0.53
136
1168
(36660697) Celiac disease serology panel - Serum
40
302
1.34
0.98
1.1
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
30
0.00
0.97
0.0
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
30
0.00
0.97
0.0
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
16
100
1.61
0.97
1.1
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
32
0.00
0.95
0.0
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
110
943
1.20
0.95
1.8
1.6
mg/l
1.3
1.5
0.29
88
730
(3026782) Osmolality of Urine
112
962
1.20
0.95
3.1
2.8
mosm/kgh2o
569.0
564.1
0.08
98
799
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
15
93
1.63
0.94
1.1
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
9
52
1.74
0.92
1.0
1.2
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
6
28
2.15
0.91
5.2
2.6
nmol/l
24.3
18.7
—
6
28
(3000330) Specific gravity of Urine by Test strip
21
301
0.69
0.91
4.4
3.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
17
254
0.66
0.90
3.4
3.0
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
16
103
1.57
0.88
1.0
1.1
—
12.3
—
0
7
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
35
457
0.75
0.87
2.8
2.3
u/l
27.8
48.4
1.31
28
395
(3013139) Helicobacter pylori Ag [Presence] in Stool
20
286
0.69
0.86
1.4
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
8
44
1.83
0.86
1.4
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
200
1817
1.14
0.83
3.9
3.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
111
0.54
0.83
1.3
1.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
359
3386
1.12
0.81
4.8
3.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
122
1381
0.86
0.80
1.2
1.3
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
25
0.00
0.79
0.0
1.3
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
26
0.00
0.78
0.0
5.8
—
71.6
—
0
5
(3017732) Neutrophils [#/volume] in Blood
38
296
1.30
0.78
2.0
2.3
e9/l
4.7
4.2
0.49
29
221
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
28
0.00
0.76
0.0
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
9
53
1.71
0.75
1.0
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
46
370
1.26
0.75
2.5
4.0
mmol/l
1.2
1.2
1.04
37
324
(3000850) Epithelial cells [#/volume] in Urine
114
1003
1.16
0.75
3.1
2.7
e6/l
7.0
5.5
0.28
102
876
(4094501)
8
133
0.60
0.74
1.1
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
100
872
1.17
0.74
2.9
3.5
mmol/l
2.5
2.5
0.43
83
761
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
7
39
1.80
0.72
1.1
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
169
1535
1.13
0.71
2.9
2.9
ng/l
1015.6
1566.2
1.34
139
1319
(40768443) Skin Pathology biopsy report
14
205
0.68
0.71
1.0
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
14
93
1.52
0.70
2.1
1.4
iu/l
26.9
34.0
—
9
82
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
368
3498
1.11
0.69
3.3
3.3
pmol/l
15.3
14.9
1.78
343
3121
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
27
1.86
0.68
1.8
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
27
1.86
0.68
1.2
1.2
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
7
42
1.67
0.68
1.0
1.4
—
114.3
—
0
7
(40760888) Immunoglobulin light chains.free panel - Serum
7
121
0.57
0.67
2.3
4.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
92
0.54
0.67
1.6
1.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
96
842
1.16
0.67
1.2
1.2
u/ml
0.7
1.4
1.60
16
205
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
43
1.63
0.67
1.1
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
156
1416
1.13
0.67
3.7
3.3
e6/l
0.7
0.6
0.22
122
1061
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
18
129
1.41
0.64
1.6
1.6
iu/ml
0.6
0.1
—
5
28
(4146454)
8
49
1.64
0.62
1.6
2.5
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(44790049)
10
64
1.57
0.59
1.4
1.7
—
—
—
0
0
(44790047)
10
64
1.57
0.59
1.4
1.7
—
—
—
0
0
(44790048)
10
64
1.57
0.59
1.4
1.7
—
—
—
0
0
(44806118)
10
64
1.57
0.59
1.4
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
8
53
1.52
0.58
1.0
1.2
—
—
—
0
0
(3036489) Thrombin time
19
141
1.36
0.57
2.2
2.2
s
20.1
22.7
1.92
14
128
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
90
0.55
0.56
2.4
6.5
—
429.9
—
0
12
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
37
1.63
0.55
1.0
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
168
1816
0.90
0.55
4.1
3.3
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
19
142
1.35
0.55
4.3
4.8
mg/l
1.1
1.5
2.13
19
131
(3000093) Morphology [Interpretation] in Blood Narrative
6
38
1.58
0.54
1.0
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
39
1.54
0.53
1.8
1.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
39
1.54
0.53
1.0
1.2
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
6
96
0.62
0.52
3.0
4.2
%
1.0
1.7
—
6
68
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
96
0.62
0.52
1.2
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
117
1279
0.90
0.48
3.7
3.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
8
119
0.67
0.46
1.0
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
42
358
1.18
0.44
1.3
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
20
252
0.79
0.44
1.4
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
146
1356
1.10
0.43
3.8
3.2
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
8
56
1.43
0.42
1.0
1.0
—
10.7
—
0
5
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
402
3894
1.08
0.42
6.1
7.3
u/l
73.0
81.8
5.94
373
3613
(3004789) Transferrin [Mass/volume] in Serum or Plasma
63
708
0.88
0.42
1.7
2.3
g/l
2.2
2.3
0.42
56
665
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
58
1.38
0.41
1.9
1.5
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.1
—
1.0
—
0
5
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
16
0.00
0.41
0.0
5.6
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
16
0.00
0.41
0.0
5.5
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
59
1.36
0.41
2.9
4.5
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
17
0.00
0.40
0.0
7.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
37
430
0.85
0.39
1.5
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
134
1247
1.09
0.39
5.3
6.9
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
26
312
0.83
0.38
1.3
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
45
392
1.16
0.38
1.4
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
186
1756
1.08
0.38
4.4
3.7
e6/l
53.7
134.9
1.00
138
1251
(3033705) Calcium.ionized [Moles/volume] in Venous blood
9
68
1.33
0.37
4.3
2.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
68
1.33
0.37
1.2
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
47
412
1.15
0.37
2.8
2.2
ug/l
14.4
7.2
0.51
42
370
(4035726)
44
502
0.87
0.37
1.2
1.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
37
1.35
0.37
1.2
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
10
72
1.39
0.37
2.9
2.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
10
135
0.74
0.36
1.6
1.6
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
133
1420
0.92
0.35
2.3
2.3
u/l
51.8
60.0
2.61
122
1285
(3013512) EKG study
143
1517
0.93
0.32
3.4
3.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
165
1563
1.07
0.32
1.9
2.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
69
629
1.11
0.31
7.8
6.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
75
687
1.10
0.31
1.2
1.2
iu/ml
39.1
45.0
0.09
19
212
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
111
1187
0.92
0.31
2.0
2.2
mg/l
3.2
2.9
0.72
91
1005
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
12
153
0.78
0.31
1.5
3.9
—
1.1
—
0
10
(3021589) Normoblasts [#/volume] in Blood
220
2291
0.94
0.29
8.0
8.9
e9/l
0.0
0.0
0.35
176
1832
(3017446) Testosterone [Moles/volume] in Serum or Plasma
35
397
0.88
0.29
2.0
1.9
nmol/l
10.6
12.6
0.69
26
350
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
7
57
1.23
0.29
1.0
1.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
85
788
1.09
0.28
1.4
1.5
g/l
2.1
2.6
1.37
52
465
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
13
103
1.27
0.28
1.5
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
17
205
0.83
0.28
2.5
1.5
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
10
76
1.32
0.28
1.1
1.8
ug/l
14.3
27.9
—
10
76
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
76
1.32
0.28
1.7
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
36
406
0.88
0.28
2.1
2.8
ml/min/173m2
126.5
59.1
0.77
12
153
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
97
906
1.08
0.27
3.1
2.9
e6/l
1.2
1.0
0.35
71
539
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
505
5133
0.94
0.27
16.6
12.4
mg/l
24.9
28.1
1.11
437
3865
(3022621) pH of Urine by Test strip
29
331
0.87
0.26
2.6
2.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
223
2314
0.95
0.26
3.2
3.9
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
73
0.68
0.26
1.6
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
42
466
0.90
0.25
2.3
2.5
e9/l
61.3
66.1
0.60
32
351
(3001122) Ferritin [Mass/volume] in Serum or Plasma
179
1865
0.95
0.24
2.3
2.6
ug/l
144.7
166.5
0.87
164
1707
(3000494) Fungus identified in Specimen by Culture
51
556
0.91
0.23
1.5
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
15
179
0.83
0.23
2.7
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
10
125
0.80
0.23
2.5
1.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
26
228
1.15
0.23
1.0
1.2
iu/ml
95.6
179.2
—
6
82
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
18
210
0.85
0.22
1.2
1.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
20
172
1.17
0.22
2.9
2.5
u/ml
0.4
0.3
0.31
13
95
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
3.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
10
0.00
0.21
0.0
7.5
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
2.1
—
2.3
—
0
5
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
13
0.00
0.21
0.0
5.2
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
13
0.00
0.21
0.0
1.0
—
283.0
—
0
7
(40768797) Stomach Pathology biopsy report
60
644
0.93
0.20
1.1
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
48
1.25
0.20
1.0
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
50
1.20
0.19
1.2
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
6
53
1.13
0.18
1.0
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
58
1.21
0.18
1.0
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
59
1.19
0.18
1.1
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
68
0.73
0.17
1.2
1.7
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
5
68
0.73
0.17
1.0
1.1
—
7.7
—
0
17
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
63
668
0.94
0.16
1.8
2.3
%
22.4
23.0
0.14
57
583
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
70
1.14
0.16
1.1
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
116
1207
0.95
0.16
2.0
2.5
—
—
—
0
0
(3000492) Spirometry study
46
430
1.07
0.15
1.8
1.5
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
11
129
0.85
0.15
2.1
2.4
ug/min
14.8
61.1
—
5
76
(40761536) Microorganisms panel - Urine sediment
41
382
1.08
0.14
4.6
3.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
99
0.81
0.13
1.1
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
28
258
1.09
0.12
2.8
2.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
36
385
0.93
0.12
2.1
4.0
%
0.0
0.1
—
8
123
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
51
536
0.95
0.11
2.2
2.6
umol/l
8.4
9.2
0.15
44
473
(3042936) Bacteria identified in Isolate by Culture
64
668
0.95
0.11
1.5
1.9
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
65
678
0.95
0.11
30.2
29.9
inr
1.2
1.5
—
10
85
(3051387) C reactive protein [Mass/volume] in Capillary blood
15
135
1.11
0.09
4.3
3.0
mg/l
26.2
28.4
—
9
83
(40761535) Cells panel - Urine sediment
43
410
1.05
0.08
4.7
2.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
7
64
1.09
0.08
2.6
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
7
65
1.08
0.08
2.3
4.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
11
123
0.89
0.08
1.4
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
42
402
1.05
0.07
2.0
3.9
%
0.9
0.6
—
10
133
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
89
867
1.03
0.07
3.3
3.0
e6/l
1.5
1.7
0.12
62
503
(3002179) Metamyelocytes/100 leukocytes in Blood
34
357
0.95
0.07
1.9
4.0
%
0.4
0.5
—
7
95
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
8
78
1.03
0.07
2.4
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
7
82
0.85
0.07
1.3
1.5
—
—
—
0
0
(4034850)
17
157
1.08
0.07
5.0
7.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
444
4466
0.98
0.06
3.9
3.9
mu/l
1.9
2.4
0.86
408
3956
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
11
121
0.91
0.06
1.2
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
10
91
1.10
0.04
1.3
1.3
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
12
111
1.08
0.04
1.5
1.5
nmol/l
50.6
40.4
0.63
12
106
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
58
593
0.98
0.03
1.4
1.4
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
15
141
1.07
0.03
2.4
2.3
%
90.7
86.3
0.29
15
135
(3004716) Salmonella sp identified in Stool by Organism specific culture
19
181
1.05
0.03
1.4
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
60
611
0.98
0.03
2.1
2.5
%
1.8
1.7
0.40
55
551
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
13
122
1.07
0.02
2.1
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
15
142
1.06
0.02
1.4
1.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
122
1230
0.99
0.02
4.2
3.3
estimate
0.0
0.0
0.50
40
385
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
13
123
1.06
0.01
1.5
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
36
354
1.02
0.00
2.1
4.0
%
0.0
0.1
—
8
100
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
13
125
1.04
0.00
1.4
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
13
126
1.03
0.00
1.4
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
13
127
1.02
0.00
1.4
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
16
162
0.99
0.00
4.9
4.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
76
757
1.00
0.00
1.9
2.4
umol/l
13.7
12.7
0.39
68
707
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
15
149
1.01
0.00
3.3
2.5
g/l
3.3
3.6
0.18
15
142
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
63
632
1.00
0.00
3.6
4.1
%
34.6
32.4
0.70
38
369
(40758292) HTLV I+II Ab panel - Serum
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
8
0.00
0.00
0.0
3.4
—
6.5
—
0
8
(3029075) Extractable nuclear Ab panel - Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
49
1.02
0.00
1.2
3.9
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
62
0.97
0.00
1.3
1.2
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
7
0.00
0.00
0.0
5.7
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
6
68
0.88
0.00
1.2
1.6
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
7
76
0.92
0.00
1.3
1.6
—
106.8
—
0
10
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
90
1.00
0.00
1.3
1.3
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
36.9
—
0
6
(3022670) pH of Venous cord blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
51
0.98
0.00
1.8
1.6
—
—
—
0
0
(1002224) Polysomnography panel
8
84
0.95
0.00
1.1
1.0
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
7
74
0.95
0.00
1.0
1.4
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
55
0.91
0.00
1.0
1.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
8.3
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
54
0.93
0.00
1.2
1.3
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
100
1000
1.00
0.00
3.7
3.1
kg/l
1.0
1.0
0.83
23
138
(3025315) Body weight
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
9
0.00
0.00
0.0
1.6
—
6349.4
—
0
9
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
5.7
—
27.9
—
0
7
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: MND – Motor neuron disease (with DMD)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).